Author

Tomoji Maeda

Observed name: TOMOJI MAEDA

Institution: Nihon Pharmaceutical University

Observed institution: Nihon Pharmaceutical University

ORCID: 0000-0003-3739-3656

Observed ORCID: 0000-0003-3739-3656

OpenAlex ID: A5024067450

Immune Checkpoint Inhibitor-induced Uveitis: Disproportionality and Timing Analyses of the Japanese Pharmacovigilance Database

2025 · NAOHITO IDE, KEN-ICHI SAKO, et al. · Anticancer Research · 3

Pork Liver Decomposition Product May Improve Frontal Lobe Function in Humans—Open Trial

2024 · Miiru Suzuki, Ikuya Sato, et al. · Brain Sciences · 3

Sex differences in thyroid dysfunction onset timing induced by immune checkpoint inhibitors: JADER disproportionality analysis

2026 · Naohito Ide, Yuki Tsuruta, et al. · Expert Opinion on Drug Safety · 2

Anti‑neuroinflammatory potential of porcine liver decomposition products in improving behavioral abnormalities: Effects on formalin‑ and LPS‑induced inflammation

2025 · Ikuya Sato, Tomoji Maeda, et al. · Biomedical Reports · 2

Effect of infusion time on risk of Bacillus cereus bloodstream infections in patients administered with BFLUID amino acid infusions via peripheral venous catheters

2024 · Atsushi Takano, Yuta Nakamaru, et al. · Biomedical Reports · 1

Infection-related and Hepatobiliary Death Outcome Reports Involving Avacopan in the Japanese Pharmacovigilance Database

2026 · NAOHITO IDE, KEN-ICHI SAKO, et al. · In Vivo

Real-world effectiveness and safety of imeglimin in Japanese patients with type 2 diabetes: a retrospective observational study

2026 · Masahiko Kimura, Masashi Yoshida, et al. · Diabetology International

Taxane-induced macular oedema: disproportionality and timing analyses using FAERS and JADER

2026 · Naohito Ide, Yoshifumi Kudo, et al. · Journal of Chemotherapy

Anti-Bacterial, Anti-Viral, and Anti-Inflammatory Properties of Kumazasa Extract: A Potential Strategy to Regulate Smoldering and Inflammation

2025 · Hideki Iwasaki, Shirol Gulam, et al. · Medicina

Pharmacokinetic Simulation of Optimal Lopinavir and Ritonavir Dose Combination for COVID-19: Boosting Lopinavir With Ritonavir

2025 · YUTA NAKAMARU, KEN-ICHI SAKO, et al. · In Vivo

Anamorelin and Conduction Defects: A Literature Review and Analysis of the Japanese Pharmacovigilance Database

2024 · NAOHIRO YABUKI, KEN-ICHI SAKO, et al. · In Vivo

Pharmacokinetic booster simulation of ritonavir improves the benefits of lopinavir for virtual patients with COVID-19

2022 · Yuta Nakamaru, Tomoji Maeda, et al. · Research Square

Efficacy of the Extract from Fermentation of Soybean and Rice Bran on Hyperglycemia

2022 · Teppei Kaku, Miiru Suzuki, et al. · YAKUGAKU ZASSHI

Engulfment of Amyloid β-protein in neurons and astrocytes mediated by MEGF10

2022 · Yu Fujita, Tomoji Maeda, et al. · Proceedings for Annual Meeting of The Japanese Pharmacological Society

Works count: 14

Citation count: 11

H-index: 2

I10-index: